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Abstract
 
Background: Erectile dysfunction (ED) is a prevalent complication of dia- betes, and oxidative stress is an important 
feature of diabetic ED. Oxidative stress-induced damage plays a pivotal role in the development of tissue altera- tions. 
However, the deleterious effects of oxidative stress in the corpus caver- nosum with the progression of diabetes 
remain unclear. The aim of this study was to evaluate systemic and penile oxidative stress status in the early and late 
stages of diabetes. 
Methods: Male Wistar streptozotocin-diabetic rats (and age-matched con- trols) were examined 2 (early) and 8 weeks 
(late) after the induction of diabe- tes. Systemic oxidative stress was evaluated by urinary H2O2 and the ratio of 
circulating reduced/oxidized glutathione (GSH/GSSG). Penile oxidative status was assessed by H2O2 production and 
3-nitrotyrosine (3-NT) forma- tion. Cavernosal endothelial nitric oxide synthase (eNOS) was analyzed by quantitative 
immunohistochemistry. Dual immunofluorescence was also per- formed for 3-NT and α-smooth muscle actin (α-
SMA) and eNOS–α-SMA. Results: There was a significant increase in urinary H2O2 levels in both diabetic groups. 
The plasma GSH/GSSG ratio was significantly augmented in late diabetes. In cavernosal tissue, H2O2 production was 
significantly increased in late diabetes. Reactivity for 3-NT was located predominantly in cavernosal smooth muscle 
(SM) and was significantly reduced in late diabetes. Quantitative immunohistochemistry revealed a significant 
decrease in eNOS levels in cavernosal SM and endothelium in late  diabetes. 
Conclusions: The findings indicate that the noxious effects of oxidative stress are more prominent in late diabetes. 
Increased penile protein oxidative modi- fications and decreased eNOS expression may be responsible for structural 
and/or functional deregulation, contributing to the progression of diabetes- associated ED. 
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Introduction 
Erectile dysfunction (ED) is a common clinical problem 
in diabetes that has detrimental impacts on the quality of 
life of men and their partners.1 The incidence of ED in 
men with diabetes is approximately threefold higher than 
in the general population.2,3 In fact, men with diabetes 
have a greater prevalence and earlier onset of ED than 
the general population, with ED affecting up to 75%   of 
tyrosine residues to 3-nitrotyrosine (3-NT) represents an 
oxidative post-translational modification of key proper- 
ties of the amino acid, including redox potential, hydro- 
phobicity, and volume, therefore altering protein 
structure and function.14 
The formation of 3-NT is mediated by RNS, such as 
peroxynitrite   anion   (ONOO−)   and   nitrogen  dioxide 
(NO2 ), formed as secondary products of NO metabo- 
lism in the presence of oxidants including O −,H O , and 
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all diabetic patients.2,3 The pathophysiology of diabetic 
ED is multifactorial, consisting predominantly of vascu- 
lar and neurological insults as a result of hyperglycemia 
induced-metabolic derangements.4 Chronic elevated 
glucose concentrations have been reported to promote 
the generation of reactive oxygen (ROS) and nitrogen 
species (RNS), and to induce the formation of advanced 
glycation end-products (AGE).5 In turn, this may cause 
changes in the bioavailability of neuronal- and 
endothelial-derived nitric oxide (NO), which may impair 
vasorelaxation mechanisms in the diabetic corpus caver- 
nosum (CC).6,7 Reductions in NO may be responsible for 
the lower response of diabetic men with ED to treatment 
with oral phosphodiesterase-5 inhibitors.8 In addition to 
changes in penile vasorelaxation, accumulation of ROS 
is associated with decreased antioxidant levels, lipid per- 
oxidation, and DNA damage, which may directly 
damage cavernosal cellular structure and function.9,10  
The deleterious effects of ROS in ED are supported by 
studies in experimental models showing that treatment 
with antioxidants reduces superoxide production (O2 ) 
and increases endothelial NO synthase (eNOS), amelio- 
rating diabetic ED.9–12 
Even though the link between oxidative stress and 
diabetic ED seems irrefutable, the redox mechanisms in 
cavernosal tissue, which may contribute to the develop- 
ment and progression of diabetic ED, remain unknown. 
Basic research studies of the effects of ROS in diabetic 
penile tissue have focused primarily on O2 production 
and its relevance in diabetes-related ED.7 However, 
another important ROS molecule, namely H2O2, has not 
been assessed in diabetic CC; H2O2 is a powerful oxidiz- 
ing agent, produced after spontaneous or superoxide dis- 
mutase (SOD)-catalysed dismutation of O −, as well as by 
other enzymatic reactions.13 Unlike O −, which remains 
at the site of production, H2O2 can diffuse across mem- 
branes and through the cytosol, potentially causing oxi- 
dative damage to most cell compartments, including 
DNA, membrane lipids, and proteins. Oxidation modi- 
fications of proteins, including protein nitration, may 
contribute to altered cell and tissue homeostasis. Protein 
nitration is a chemical process in which nitro groups (–
NO2) are preferentially introduced in certain amino 
acids,  including  tyrosines.  In  fact,  protein  nitration of 
transition metal centers.15 These oxidative reactions 
involving NO, further decrease its bioavailability, aggra- 
vating endothelial dysfunction and severely affecting 
vasorelaxation events. Increased systemic and tissue 
levels of 3-NT have been reported in diabetes.16,17 
However, the presence of 3-NT in diabetic erectile tissue 
has not been thoroughly evaluated with the progression 
of the disease. In addition to direct inactivation of NO 
when promoting 3-NT formation, cavernosal reductions 
in NO may be related to changes in eNOS expression,18 
contributing to a more severe impairment of diabetic 
CC endothelial-dependent and smooth muscle (SM) 
relaxation. 
Taking these issues into consideration, our intention 
was to investigate oxidative stress-induced modifications 
in diabetic CC with the progression of the disease that 
may contribute to the degeneration of cellular and 
molecular mechanisms, essential for tissue homeostasis 
and erectile function. Thus, the aim of the present study 
was to characterize the systemic and penile redox status 
in early (2 weeks) and late (8 weeks) stages of streptozo- 
tocin (STZ)-induced type 1 diabetes. In addition, we 
evaluated the impact of the duration of diabetes on cav- 
ernosal production of H2O2 and 3-NT formation and 
whether the progression of the disease significantly 
changes eNOS expression. Elucidating oxidative stress- 
induced pathways involved in the progression of diabetic 
ED will provide a better insight into the deleterious 
effects of diabetes both systemically and at the penile 
level. 
 
 
Methods 
Animals 
All experimental and animal handling procedures were 
conducted in accordance with the ethical guidelines pro- 
posed by the Portuguese General Veterinary Directorate 
(DGV) in the Directive of 24 November 1986 (86/609/ 
EEC), with the recommendations of 18 June 2007 (2007/ 
526/EC) proposed by the Council of the European 
Communities. In all, 40 male Wistar rats (280–350 g; 
Charles River Laboratories, Barcelona, Spain) were 
maintained in a 12-h day–light cycle with free access  to 
  
 
food and tap water. Rats were initially randomly divided 
into two groups (n = 20 in each), a diabetic group and an 
age-matched healthy control group. Type 1 diabetes was 
induced by a single intraperitoneal injection of 50 mg/kg 
streptozotocin (STZ; Sigma-Aldrich, Sintra, Portugal) 
dissolved in 0.1 mol/L citrate buffer (pH 4.5); age- 
matched control rats were injected with vehicle. Diabetes 
(glucose levels >250 mg/dL) was successfully induced 
and confirmed by Accu-Check glucose measurements 
(Roche Diagnostics, Mannheim, Germany). The effects 
of oxidative stress were evaluated in early (2 weeks) and 
late (8 weeks) diabetes, as well as in age-matched con- 
trols (n = 10 in each group). At both 2 and 8 weeks after 
STZ or vehicle injection, rats were place in metabolic 
cages and urine was collected over a 24-h period. Rats 
were then killed, blood samples collected, and their 
penises excised. A fragment of penile tissue was weighed 
(80–120 mg) and used to assess H2O2 release; the remain- 
ing tissues were stored at −80°C for subsequent protein 
extraction or embedding in  OCT. 
 
Quantification of H2O2 
In the present study, H2O2 levels were evaluated in 
diluted urine samples using the Amplex Red Hydrogen 
Peroxide Assay kit (Invitrogen, Carlsbad, CA, USA) 
according to the manufacturer’s instructions. Briefly, 
urine was diluted in kit reaction buffer (1 : 10 control 
animals and 1 : 50 diabetic animals) according to the 
instructions provided with the kit. Fluorescence intensity 
was then measured in a multiplate reader (Spectramax 
Gemini XS; Molecular Devices, Sunnyvale, CA, USA). 
Urinary H2O2 production is given as nmol H2O2/mg crea- 
tinine. Using the same method, H2O2 release was evalu- 
ated in penile tissue fragments that had been incubated 
for 90 min at 37°C in oxygenated Krebs’–HEPES buffer 
(composition [in mmol/L]: NaCl 118.0; KCl 4.5; CaCl2 
2.5; MgCl2 1.20; K2HPO4 1.2; NaHCO3 25.0; Na-HEPES 
25.0; glucose 5.0, pH 7.4). Levels of H2O2 in CC samples 
are expressed as nmol H2O2/mg tissue. 
 
Determination of the reduced/oxidized glutathione ratio 
The reduced/oxidized glutathione (GSH/GSSG) ratio 
was evaluated in blood samples chromatographically 
using a commercially available kit (Immundiagnostik, 
Bensheim, Germany) and a Shimadzu LC system (Shi- 
madzu, Kyoto, Japan) equipped with an LC 20AD 
pump, a DGU-20A5 degasser, and an RF-10AXL fluo- 
rescence detector (FLD). Separation was performed on a 
Luna column (C18, 5-μm particle size, 4.60 × 150 mm; 
Phenomenex, Torrance, CA, USA) at room temperature 
(20 ± 1°C). The injected volume was 20 µL and LCsolu- 
tion  software  version  2.1  (Shimadzu)  was  used     for 
control and data processing. The chromatographic con- 
ditions used were as described in the manual that came 
with the kit. Fluorescence intensity was measured at exci- 
tation and emission wavelengths of 385 and 515 nm, 
respectively, the flow rate was 1.0 mL/min, and chro- 
matograms were recorded. 
 
 
Western blotting for 3-NT 
Penile protein extraction and quantification was per- 
formed as described previously.19 Briefly, 8 µg total 
protein was separated by electrophoresis on a 10% 
sodium dodecyl sulfate–polyacrylamide gel. After trans- 
fer, nitrocellulose membranes were incubated overnight 
with the cross-reactive rabbit anti-3-NT polyclonal anti- 
body (1 : 1000 dilution; AB5411; Upstate, Millipore, 
Temecula, CA, USA). Antibody binding was detected 
after incubation with the respective secondary horserad- 
ish peroxidase-conjugated antibody (1 : 2000; Santa 
Cruz Biotechnology, Santa Cruz, CA, USA) and using 
enhanced chemiluminescence (ECL kit; Amersham Bio- 
sciences, Buckinghamshire, UK). Membranes were 
stripped and re-probed with a rabbit anti-human β-actin 
antibody (1 : 3000; Abcam, Cambridge, UK), as 
described for 3-NT. Changes in 3-NT protein expression 
were quantified by densitometry (Vision Works LS Soft- 
ware; UVP, Upland, CA, USA). Results are expressed as 
mean relative intensity and were normalized against the 
β-actin protein signal. 
 
Dual immunofluorescence 
Expression of 3-NT and eNOS was assessed by dual 
immunofluorescence for both proteins and α-smooth 
muscle actin (α-SMA).20 Briefly, sections were incubated 
with a mixture of the cross-reactive primaries antibodies, 
namely: rabbit anti-3-NT (1 : 400; Upstate, Millipore) 
and mouse anti-human α-SMA (1 : 500; clone ASM; 
Chemicon International, Temecula, UK); and rabbit 
anti-human eNOS (1 : 85; Abcam) and mouse anti- 
human α-SMA (1 : 500; clone ASM; Chemicon Interna- 
tional). Slides were incubated with the following 
respective secondary antibodies: red fluorochrome- 
conjugated donkey anti-rabbit (1 : 1000; Alexa 568; 
Invitrogen) and green fluorochrome-conjugated donkey 
anti-mouse (1 : 1000; Alexa 488; Invitrogen). As a nega- 
tive control, the primary antibodies were omitted. Nuclei 
were counterstained with 4′,6′-diamidino-2-phenylindole 
(DAPI; Invitrogen) and slides were observed under a 
fluorescence microscope (Imager.Z1; Zeiss, Göttingen, 
Germany) and images captured (Carl Zeiss MicroImag- 
ing,  Göttingen, Germany). 
  
 
 
Quantitative immunostaining for eNOS 
Immunodetection of eNOS was performed in penile 
tissues from late (8 weeks) diabetic and non-diabetic 
control groups using the streptavidin–biotin peroxidase 
method.20 Briefly, CC sections were incubated overnight 
with the primary antibody, a cross-reactive rabbit anti- 
eNOS antibody (1 : 85; Abcam), followed by the second- 
ary antibody (Santa Cruz Biotechnology) and the 
avidin–biotin complex reagent (Vector Laboratories, 
Burlingame, CA, USA). As a negative control, the 
primary antibody was omitted. Diaminobenzidine (DAB 
kit; Abcam) was used as the chromogen and sections 
were counterstained using hematoxylin. Immunostain- 
ing was visualized under an Olympus AH3-RFCA 
microscope and images were captured using an Olympus 
C-35AD-4 camera (Olympus Imaging Europa, 
Hamburg, Germany). Signal intensity was quantified as 
described previously21 using ImageJ color deconvolution 
(v.1.37a; National Institutes of Health, Bethesda, MD, 
USA). A DAB threshold value of 25 was selected for 
eNOS by measuring the lowest and highest mean optical 
density values in 10 random DAB-positive images. For 
each image, the sum of the intensity values in the regions 
of interest (ROI) was divided by the ROI total area, 
producing an average intensity unitless value for eNOS 
staining. All intensity values within the same group (non- 
diabetic and diabetic) were averaged to calculate an 
overall value, a relative measurement of eNOS protein 
levels. 
 
Statistical analysis 
Statistical analyses were performed using GraphPad 
Prism version 5.0 (GraphPad, San Diego, CA, USA). 
Data are presented as the mean ± SE. The significance of 
differences between groups for changes in H2O2 produc- 
tion, the GSH/GSSG ratio, and quantitative immunos- 
taining was calculated using Student’s t-test. For 
Western blotting, significant differences between groups 
were determined using the one-way analysis of variance 
(ANOVA) followed by the Bonferroni test. Two-sided 
P < 0.05 was considered significant. 
 
 
Results 
Evaluation of systemic oxidative stress in non-diabetic 
and diabetic rats 
To assess systemic redox status in early and late diabetes, 
urinary  H O   levels  and  the  plasma  GSH/GSSG ratio 
(2 weeks) and late (8 weeks) diabetic rats compared with 
their respective age-matched controls (P < 0.0001 and 
P = 0.042, respectively; Fig. 1). In contrast, there were no 
significant changes in the GSH/GSSG ratio in early dia- 
betic rats compared with  the  age-matched  control 
(Fig. 2). However, the GSH/GSSG ratio decreased sig- 
nificant in late diabetic rats compared with the age- 
matched control (P = 0.029; Fig. 2). The increase in H2O2 
levels and decreased GSH/GSSG ratio with the progres- 
sion of diabetes indicate an imbalance in the systemic 
redox status towards the promotion of oxidative 
damage. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1  Systemic quantification of H2O2 levels in urine samples of 
2 and 8-week diabetic rats and age-matched controls. Urinary H2O2 
was significantly increased in both groups of diabetic rats when 
compared with respective age-matched controls. Data are  the  
mean ± SE. *P < 0.05, ****P < 0.0001 compared with control. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2 Chromatographic measurement of reduced/oxidized glu- 
tathione (GSH/GSSG) in the plasma of early and advanced   diabetic 
2    2 animals. A significant decrease of plasmatic GSH/GSSG ratio was 
were determined. There were significant increases in 
urinary H2O2 concentrations in samples from both   early 
observed only in the plasma of 8-weeks diabetic rats. Data are the 
mean ± SE. *P < 0.05 compared with control. 
  
 
 
Local production of H2O2 by penile tissue 
We next evaluated whether the presence of specific oxi- 
dative markers increased in diabetic cavernosal tissue 
with progression of the disease. There was a tendency for 
an increase in H2O2 release from penile tissue from early 
diabetic rats compared with age-matched controls, but 
the  difference  failed  to  reach  statistical    significance 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3 Penile measurement of H2O2 production in 2 and 8-week 
diabetic rats and age-matched controls. Data showed that at 2-weeks 
there was a non-significant increase in H2O2 release. A significant 
augmentation was verified only in penile H2O2 levels in the 8-weeks 
diabetic group, when compared  with  controls.  Data  are  the  
mean ± SE. **P < 0.01 compared with control. 
(Fig. 3). However, with progression of the disease, H2O2 
production by erectile tissue increased significantly in the 
late   diabetic   compared   with    non-diabetic    group 
(P = 0.0013; Fig. 3). Corroborating the results of sys- 
temic oxidative stress evaluation, these data suggest that, 
in penile tissue, H2O2-induced oxidative stress is mainly 
detected in the advanced stage of  diabetes. 
Assessment of penile 3-NT content in early and late 
staged diabetes 
To obtain further insight into the noxious effects of oxi- 
dative stress in diabetic CC, we evaluated oxidative 
protein damage by detecting protein tyrosine nitration. 
Damaging changes to diabetic erectile tissue proteins 
were assessed by detection of 3-NT, a stable marker of 
protein oxidative damage. Expression of 3-NT was 
quantified by Western blotting and its cavernosal cellular 
localization was evaluated by double immunolabeling 
for 3-NT/α-SMA. As shown in Fig. 4a, three bands were 
identified for 3-NT formation, two corresponding to  
high molecular weight proteins (Bands A and B) and one 
corresponding to low molecular weight protein (Band 
C). There was no significant difference in cavernosal 3-
NT between the early diabetic and age-matched control 
groups. However, there was a significant increase in 
protein nitration, particularly in proteins of Bands B and 
C, in late diabetic CC compared with the non- diabetic 
group (P < 0.01; Fig. 4b). Furthermore, signifi- 
 
 
 
 
 
 
 
 
Figure 4 3-Nitrotyrosine (3-NT) protein 
quantification and expression pattern in 
control and diabetic cavernosal samples. (a, 
b) Western blotting results revealed a sig- 
nificant increase in penile protein oxidative 
damage in 8-week diabetic animals (D8) as 
compared to age-matched controls (C8) con- 
trols and to 2-weeks diabetic samples (D2). 
Densitometry and mean relative intensity 
quantification by comparing the intensity of 
3-NT with the intensity of the β-actin 
protein. Data presented as mean relative 
intensity ± SE. **P < 0.01, *P < 0.05. (c) 
3-NT profile as assessed by double immu- 
nofluorescence for 3-NT and α-smooth 
muscle actin (α-SMA), revealed a perivascu- 
lar smooth muscle and trabecular expres- 
sion pattern for 3-NT. DAPI, 4′,6′-diamidino- 
2-phenylindole (nuclear staining) (nuclear 
staining). Bars, 100 μm. 
  
 
cant augmentation of protein nitration was detected with 
the progression of diabetes when comparing erectile 
tissue from late with early  diabetic  rats  (P < 0.05; 
Fig. 4a,b). With regard to the pattern of 3-NT oxidative 
changes, there was abundant formation of tyrosine resi- 
dues in diabetic cavernosal smooth muscle cells (SMC), 
as well as in the lining endothelium and trabecular fibro- 
blasts (Fig. 4c). A similar pattern was found in non- 
diabetic CC (Fig. 4c), although with obviously lower 3-
NT expression. These data corroborate the results 
obtained by Western blotting and reinforce the idea that 
increased penile protein oxidative modifications occur 
with the progression of diabetes. In addition to direct 
inactivation of NO when promoting 3-NT formation, a 
cavernosal reduction in NO may be related to changes in 
eNOS expression. 
 
eNOS protein expression in diabetic cavernosal tissue 
Changes in the activation of pathways involved in NO 
synthesis and/or bioavailability have been reported as 
consequence of hyperglycemia-induced oxidative 
stress.6,7 In addition, changes in eNOS may aggravate 
diabetic vascular-related events. Because oxidative  
stress has a more pronounced effect in late-stage diabe- 
tes, we quantified eNOS immunoreactivity staining in 
DAB-labeled sections 8 weeks after STZ injection using 
a color deconvolution method. In addition, we identi- 
fied rat cavernosal components expressing eNOS using 
dual immunofluorescence for eNOS/α-SMA. There was 
a significant decrease in eNOS signal intensity in late 
diabetic compared with age-matched  control  rats 
(39.25 ± 2.01 vs 50.34 ± 1.86, respectively; P = 0.0037; 
Fig. 5a,b). With regard to the expression profile, eNOS 
in non-diabetic penile tissue was expressed in perivas- 
cular SMCs and particularly in the sinusoidal endothe- 
lium. A similar pattern was found in diabetic corporeal 
tissue (Fig. 5c). A decrease in eNOS expression indi- 
cates a reduction in diabetic cavernosal eNOS and 
impairment of vasorelaxation mechanisms, affecting 
erectile function. 
 
 
Discussion 
Diabetic men have an approximate threefold increased 
risk of the development of ED compared with non- 
diabetic individuals.2,3 It is known that hyperglycemia- 
induced increases in the production of AGEs, ROS, and 
RNS impair NO bioavailability and affect penile tissue, 
leading to changes in endothelium-dependent vasorelax- 
ation mechanisms.5–7 In fact, mounting evidence indi- 
cates that oxidative stress plays a significant role in 
diabetes-associated   ED.9–12   However,   basic  research 
studies in experimental models of diabetes have focused 
primarily on evaluating ROS production and the effects 
of antioxidant administration at one specific time 
point.7,9–12 Furthermore, and because oxidative stress 
involves multiple and complex mechanisms, there is a 
gap of information regarding the presence and function 
of oxidative stress changes in diabetic cavernosal tissue 
with the progression of the disease. It is the case of penile 
H2O2 production and the formation of 3-NT protein oxi- 
dative modifications. Therefore, we evaluated levels of 
cavernosal release of H2O2, quantified 3-NT formation, 
and assessed changes in eNOS expression in early (2 
weeks) and late (8 weeks) diabetes. 
First, in order to characterize the overall redox status 
of diabetic rats 2 and 8 weeks after STZ injection, we 
quantified urinary production of H2O2 and evaluated cel- 
lular defense mechanisms by measuring the plasma 
GSH/GSSG ratio. The results reveal a significant 
increase in H2O2 levels in both the early and late diabetic 
groups. Because H2O2, a powerful diffusible oxidizing 
molecule, is relatively stable in aqueous solution, direct 
measurement of H2O2 is relatively easy. Low levels of 
H2O2 have a physiological role in cell signaling. 
However, higher concentrations of H2O2 induce oxida- 
tive stress and contribute to cell damage. Primarily, H2O2 
acts in an indirect manner in the presence of transition 
metal ions originating highly reactive hydroxyl radicals, 
which can damage DNA, lipids, and proteins.13 In fact, it 
has been reported that the measurement of urinary H2O2 
may be a valuable biomarker for the detection of 
increased systemic oxidative stress associated with 
pathological conditions, including diabetes.22 In agree- 
ment with our results, previous studies have demon- 
strated augmentation of urinary H2O2 in STZ-diabetic 4 
and 8 weeks after disease onset.23 Accordingly, it is 
known that diabetes induces significant pathophysiologi- 
cal alterations with the progression of the disease, and 
therefore an increment of systemic oxidative stress is 
expected at later stages. Nonetheless, the observed incre- 
ment in urinary H2O2 2 weeks after the onset of diabetes 
indicates that the production of this ROS may be an 
early oxidative event in diabetes. 
Next, we investigated the plasma GSH/GSSG ratio in 
early and late diabetes. The GSH/GSSG ratio is the 
product of an antioxidant endogenous system consisting 
of enzymes with free radical-scavenging capacities, 
which oxidize GSH to GSSG and reduce the latter to 
GSH. Thus, GSH has a central role as an antioxidant 
and is the product of the action of glutathione reductase 
on GSSG.24 Therefore, the plasma GSH/GSSG ratio can 
be an indicator of systemic redox status. The results of 
the present study revealed a significant reduction in the 
plasma GSH/GSSG ratio of late diabetic rats   compared 
  
 
 
 
Figure 5 Quantitative immunohistochemistry of endothelial nitric oxide synthase (eNOS) in 2 and 8-weeks diabetic corporeal samples. (a,b) 
eNOS protein expression levels as quantified in eNOS-DAB stained slides by ImageJ color deconvolution, revealed a significant decrease in 
eNOS in diabetic corpus cavernosum (CC) compared with the age-matched control (39.25 ± 2.01 vs 50.34 ± 1.86, respectively). Data presented 
as mean ± SE. **P < 0.01 compared with control. RGB, red, green, blue RGB, xxx. Red Green Blue (RGB) (c) Colocalization of eNOS and α-
smooth muscle actin (α-SMA) by dual immunolabeling demonstrated that eNOS protein was predominantly present in cavernosal endothelial 
cells and smooth muscle cells in samples from both non-diabetic and diabetic groups. DAPI, 4′,6′-diamidino-2-phenylindole (nuclear staining); 
C8, control group at 8 weeks; D8, 8-week diabetics (nuclear staining); C8, control group at 8 weeks; D8, 8-week diabetics. Bars,   100 μm. 
 
 
with the non-diabetic age-matched control group, sug- 
gesting impairment of this system and an increment in 
systemic oxidative stress with the progression of diabe- 
tes. In fact, our data corroborate a previous study that 
also reported a decreased plasma GSH/GSSG ratio in a 
diabetic model.25 According to our results, this antioxi- 
dant enzyme system appears to be altered as consequence 
of prolonged diabetes, thus exacerbating systemic oxida- 
tive stress. 
After characterizing the systemic redox status in the 
early and late diabetic rats, we evaluated local cavernosal 
oxidative stress, namely the production of H2O2 and 3-
NT formation, and eNOS expression. Despite data 
showing an increment of H2O2 levels in diabetic 
tissues,26,27 to date H2O2 production has not been   evalu- 
ated in diabetic CC with the progression of the disease. 
The results of the present study showed a tendency for an 
increase in cavernosal H2O2 release in early diabetes, 
which because statistically significant in late diabetes. 
Because H2O2 is a lipid-soluble molecule, it seems rea- 
sonable that systemically, in early diabetes, we already 
observe a significant increment in the urine and that in 
the penis, this increase becomes more prominent in the 
later stage of the disease. Tissue function is also affected 
by ROS-induced damage to proteins.14 In fact, 3-NT- 
modified proteins are susceptible to changes in structure, 
function, enzyme activity, and signaling pathway activa- 
tion.14,15 Because of their role and because 3-NT protein 
modifications have not been evaluated thoroughly in 
cavernosal tissue with the progression of diabetes, we 
  
 
quantified and characterized 3-NT expression in early 
and late diabetes. There was a significant increase in 3-
NT-containing proteins of different molecular weights 
in late diabetic erectile tissue compared with the age- 
matched control and early diabetic groups. Corroborat- 
ing our data, previous studies have reported an 
increment of penile 3-NT formation, as analyzed at 
single time points after the induction of diabetes, using 
immunohistochemical techniques.28–30 Dual immuno- 
fluorescence for α-SMA + 3-NT revealed a more promi- 
nent expression of 3-NT in SMCs, trabecular fibroblasts, 
and some labeling also in the lining sinusoids of late 
diabetic CC. This expression profile of 3-NT in diabetic 
erectile tissue is in agreement with previous reports,28,30 
indicating that 3-NT formation may affect several cell 
compartments promoting tissue malfunction. Consistent 
with H2O2 data, more severe oxidative lesions in proteins 
were detected in late diabetes as consequence of sus- 
tained hyperglycemia and oxidative stress-induced 
molecular modifications. 
In addition to the aforementioned changes, it is known 
that oxidative reactions involving ROS and RNS 
promote deregulations in NO bioavailability, either by 
directly rescuing it or by inducing changes in eNOS.6,31 It 
is well established that impairment in NO physiology 
alters penile vascular tone and relaxation of corporeal 
smooth muscle, hampering penile vasorelaxation and 
erection.6,7 Because more prominent changes were 
observed at the later time point of diabetes, we evaluated 
eNOS protein expression in diabetic cavernosal tissue by 
quantitative immunohistochemistry in rats 8 weeks after 
the induction of diabetes. There was a significant reduc- 
tion in eNOS protein expression in penile tissue of late 
diabetic rats. Although this quantification method has 
not been used to quantify eNOS in CC previously, it was 
found to be a reliable tool because our data corroborate 
previous publications in which decreased eNOS expres- 
sion was verified by different techniques.18,32 Further, we 
evaluated the eNOS expression pattern and detected spe- 
cific signals in the cavernosal endothelium and in the 
SMC component, in agreement with recent  studies.18,32 
Overall, we observed an increase in systemic and local 
oxidative status in penile tissue with the progression of 
diabetes. As the disease progressed, we detected an incre- 
ment in cavernosal H2O2 production, increased oxidative 
injury to proteins, and changes in eNOS protein expres- 
sion. These may hamper erectile tissue cellular and/or 
molecular function and vasorelaxation events, contrib- 
uting to ED  progression. 
The results of the present study demonstrate that the 
noxious effects of oxidative stress are more prominent in 
advanced stages of diabetes. We observed an imbalance 
in systemic oxidative stress mechanisms, with an increase 
in H2O2 production and impairment in the endogenous 
antioxidant GSH/GSSG system. Locally, in diabetic 
penile tissue, we detected a marked increase in oxidative 
markers, namely H2O2, and augmentation of oxidative 
stress-induced protein modifications, which may be 
responsible for promoting structural and/or functional 
changes in cellular and/or molecular mechanisms essen- 
tial for the normal erectile process. A reduction in eNOS 
expression was also observed with the progression of 
diabetes, indicating a deregulation in vasorelaxation 
mechanisms. 
Overall, increased cavernosal oxidative stress, aug- 
mented protein oxidative damage, and decreased eNOS 
expression highlight the role of deleterious events 
induced by diabetes that contribute to ED and 
strengthen the relevance of preventative antioxidant 
therapy. 
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